nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP2D6—Niacin—atherosclerosis	0.106	0.169	CbGbCtD
Cyclobenzaprine—CYP2D6—Simvastatin—atherosclerosis	0.0838	0.134	CbGbCtD
Cyclobenzaprine—CYP2D6—Lovastatin—atherosclerosis	0.082	0.131	CbGbCtD
Cyclobenzaprine—CYP2D6—Pravastatin—atherosclerosis	0.082	0.131	CbGbCtD
Cyclobenzaprine—CYP3A4—Rosuvastatin—atherosclerosis	0.0573	0.0916	CbGbCtD
Cyclobenzaprine—CYP3A4—Ezetimibe—atherosclerosis	0.0573	0.0916	CbGbCtD
Cyclobenzaprine—CYP3A4—Simvastatin—atherosclerosis	0.0533	0.0851	CbGbCtD
Cyclobenzaprine—CYP3A4—Pravastatin—atherosclerosis	0.0521	0.0833	CbGbCtD
Cyclobenzaprine—CYP3A4—Lovastatin—atherosclerosis	0.0521	0.0833	CbGbCtD
Cyclobenzaprine—HTR2A—arteriole—atherosclerosis	0.00772	0.297	CbGeAlD
Cyclobenzaprine—HTR2A—vein—atherosclerosis	0.0046	0.177	CbGeAlD
Cyclobenzaprine—HTR2A—hindlimb—atherosclerosis	0.00306	0.118	CbGeAlD
Cyclobenzaprine—HTR2A—appendage—atherosclerosis	0.00262	0.101	CbGeAlD
Cyclobenzaprine—HTR2A—artery—atherosclerosis	0.00188	0.0722	CbGeAlD
Cyclobenzaprine—HTR2A—endothelium—atherosclerosis	0.00158	0.061	CbGeAlD
Cyclobenzaprine—HTR2A—blood vessel—atherosclerosis	0.00146	0.0562	CbGeAlD
Cyclobenzaprine—Pheniramine—HRH1—atherosclerosis	0.00121	0.096	CrCbGaD
Cyclobenzaprine—Flatulence—Rosuvastatin—atherosclerosis	0.00114	0.00383	CcSEcCtD
Cyclobenzaprine—Hepatitis—Lovastatin—atherosclerosis	0.00112	0.00378	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Niacin—atherosclerosis	0.00111	0.00374	CcSEcCtD
Cyclobenzaprine—Clofedanol—HRH1—atherosclerosis	0.00111	0.0874	CrCbGaD
Cyclobenzaprine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.0011	0.00371	CcSEcCtD
Cyclobenzaprine—Hepatitis—Ezetimibe—atherosclerosis	0.0011	0.00371	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Ezetimibe—atherosclerosis	0.00109	0.00368	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Pravastatin—atherosclerosis	0.00109	0.00368	CcSEcCtD
Cyclobenzaprine—Weight increased—Pravastatin—atherosclerosis	0.00108	0.00364	CcSEcCtD
Cyclobenzaprine—Angioedema—Rosuvastatin—atherosclerosis	0.00105	0.00355	CcSEcCtD
Cyclobenzaprine—Hepatitis—Simvastatin—atherosclerosis	0.00105	0.00354	CcSEcCtD
Cyclobenzaprine—Stomatitis—Niacin—atherosclerosis	0.00105	0.00353	CcSEcCtD
Cyclobenzaprine—Jaundice—Niacin—atherosclerosis	0.00105	0.00353	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00104	0.00351	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Pravastatin—atherosclerosis	0.00104	0.00349	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00104	0.00349	CcSEcCtD
Cyclobenzaprine—Jaundice—Pravastatin—atherosclerosis	0.00103	0.00347	CcSEcCtD
Cyclobenzaprine—Sweating—Niacin—atherosclerosis	0.00103	0.00347	CcSEcCtD
Cyclobenzaprine—Doxylamine—HRH1—atherosclerosis	0.00101	0.08	CrCbGaD
Cyclobenzaprine—Alopecia—Lovastatin—atherosclerosis	0.000992	0.00334	CcSEcCtD
Cyclobenzaprine—Myalgia—Rosuvastatin—atherosclerosis	0.000982	0.00331	CcSEcCtD
Cyclobenzaprine—Alopecia—Ezetimibe—atherosclerosis	0.000973	0.00328	CcSEcCtD
Cyclobenzaprine—Hepatitis—Niacin—atherosclerosis	0.000964	0.00325	CcSEcCtD
Cyclobenzaprine—Flatulence—Lovastatin—atherosclerosis	0.000963	0.00325	CcSEcCtD
Cyclobenzaprine—Tripelennamine—HRH1—atherosclerosis	0.000962	0.0761	CrCbGaD
Cyclobenzaprine—Hypoaesthesia—Niacin—atherosclerosis	0.000959	0.00323	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Lovastatin—atherosclerosis	0.000957	0.00323	CcSEcCtD
Cyclobenzaprine—Olopatadine—HRH1—atherosclerosis	0.000951	0.0752	CrCbGaD
Cyclobenzaprine—Hepatitis—Pravastatin—atherosclerosis	0.000949	0.0032	CcSEcCtD
Cyclobenzaprine—Confusional state—Rosuvastatin—atherosclerosis	0.000949	0.0032	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000944	0.00318	CcSEcCtD
Cyclobenzaprine—Flatulence—Ezetimibe—atherosclerosis	0.000944	0.00318	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Pravastatin—atherosclerosis	0.000942	0.00318	CcSEcCtD
Cyclobenzaprine—Alopecia—Simvastatin—atherosclerosis	0.000928	0.00313	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000921	0.00311	CcSEcCtD
Cyclobenzaprine—Vision blurred—Lovastatin—atherosclerosis	0.000921	0.0031	CcSEcCtD
Cyclobenzaprine—Tremor—Lovastatin—atherosclerosis	0.000915	0.00309	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000907	0.00306	CcSEcCtD
Cyclobenzaprine—Flatulence—Simvastatin—atherosclerosis	0.000901	0.00304	CcSEcCtD
Cyclobenzaprine—Tinnitus—Niacin—atherosclerosis	0.000899	0.00303	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Simvastatin—atherosclerosis	0.000895	0.00302	CcSEcCtD
Cyclobenzaprine—Angioedema—Lovastatin—atherosclerosis	0.000893	0.00301	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000889	0.003	CcSEcCtD
Cyclobenzaprine—Tinnitus—Pravastatin—atherosclerosis	0.000885	0.00298	CcSEcCtD
Cyclobenzaprine—Dimetindene—HRH1—atherosclerosis	0.000884	0.0699	CrCbGaD
Cyclobenzaprine—Malaise—Lovastatin—atherosclerosis	0.000881	0.00297	CcSEcCtD
Cyclobenzaprine—Vertigo—Lovastatin—atherosclerosis	0.000878	0.00296	CcSEcCtD
Cyclobenzaprine—Angioedema—Ezetimibe—atherosclerosis	0.000876	0.00295	CcSEcCtD
Cyclobenzaprine—Leukopenia—Lovastatin—atherosclerosis	0.000875	0.00295	CcSEcCtD
Cyclobenzaprine—Alimemazine—HRH1—atherosclerosis	0.000868	0.0686	CrCbGaD
Cyclobenzaprine—Malaise—Ezetimibe—atherosclerosis	0.000864	0.00291	CcSEcCtD
Cyclobenzaprine—Vision blurred—Simvastatin—atherosclerosis	0.000861	0.0029	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Niacin—atherosclerosis	0.000861	0.0029	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000857	0.00289	CcSEcCtD
Cyclobenzaprine—Tremor—Simvastatin—atherosclerosis	0.000856	0.00289	CcSEcCtD
Cyclobenzaprine—Alopecia—Niacin—atherosclerosis	0.000852	0.00287	CcSEcCtD
Cyclobenzaprine—Insomnia—Rosuvastatin—atherosclerosis	0.000851	0.00287	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000848	0.00286	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Pravastatin—atherosclerosis	0.000848	0.00286	CcSEcCtD
Cyclobenzaprine—Palpitations—Ezetimibe—atherosclerosis	0.000847	0.00285	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000845	0.00285	CcSEcCtD
Cyclobenzaprine—Alopecia—Pravastatin—atherosclerosis	0.000839	0.00283	CcSEcCtD
Cyclobenzaprine—Angioedema—Simvastatin—atherosclerosis	0.000835	0.00281	CcSEcCtD
Cyclobenzaprine—Chest pain—Lovastatin—atherosclerosis	0.000832	0.0028	CcSEcCtD
Cyclobenzaprine—Myalgia—Lovastatin—atherosclerosis	0.000832	0.0028	CcSEcCtD
Cyclobenzaprine—Anxiety—Lovastatin—atherosclerosis	0.000829	0.00279	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000828	0.00279	CcSEcCtD
Cyclobenzaprine—Hypertension—Ezetimibe—atherosclerosis	0.000827	0.00279	CcSEcCtD
Cyclobenzaprine—Flatulence—Niacin—atherosclerosis	0.000827	0.00279	CcSEcCtD
Cyclobenzaprine—Malaise—Simvastatin—atherosclerosis	0.000824	0.00278	CcSEcCtD
Cyclobenzaprine—Tension—Niacin—atherosclerosis	0.000823	0.00278	CcSEcCtD
Cyclobenzaprine—Discomfort—Lovastatin—atherosclerosis	0.000822	0.00277	CcSEcCtD
Cyclobenzaprine—Vertigo—Simvastatin—atherosclerosis	0.000821	0.00277	CcSEcCtD
Cyclobenzaprine—Leukopenia—Simvastatin—atherosclerosis	0.000818	0.00276	CcSEcCtD
Cyclobenzaprine—Chest pain—Ezetimibe—atherosclerosis	0.000816	0.00275	CcSEcCtD
Cyclobenzaprine—Myalgia—Ezetimibe—atherosclerosis	0.000816	0.00275	CcSEcCtD
Cyclobenzaprine—Nervousness—Niacin—atherosclerosis	0.000815	0.00275	CcSEcCtD
Cyclobenzaprine—Flatulence—Pravastatin—atherosclerosis	0.000814	0.00274	CcSEcCtD
Cyclobenzaprine—Dry mouth—Lovastatin—atherosclerosis	0.000814	0.00274	CcSEcCtD
Cyclobenzaprine—Tension—Pravastatin—atherosclerosis	0.000811	0.00273	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Pravastatin—atherosclerosis	0.000809	0.00273	CcSEcCtD
Cyclobenzaprine—Discomfort—Ezetimibe—atherosclerosis	0.000806	0.00272	CcSEcCtD
Cyclobenzaprine—Constipation—Rosuvastatin—atherosclerosis	0.000805	0.00271	CcSEcCtD
Cyclobenzaprine—Confusional state—Lovastatin—atherosclerosis	0.000804	0.00271	CcSEcCtD
Cyclobenzaprine—Nervousness—Pravastatin—atherosclerosis	0.000802	0.00271	CcSEcCtD
Cyclobenzaprine—Dry mouth—Ezetimibe—atherosclerosis	0.000798	0.00269	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000797	0.00269	CcSEcCtD
Cyclobenzaprine—Vision blurred—Niacin—atherosclerosis	0.000791	0.00267	CcSEcCtD
Cyclobenzaprine—Bromodiphenhydramine—HRH1—atherosclerosis	0.000791	0.0625	CrCbGaD
Cyclobenzaprine—Confusional state—Ezetimibe—atherosclerosis	0.000789	0.00266	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000782	0.00264	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000781	0.00263	CcSEcCtD
Cyclobenzaprine—Vision blurred—Pravastatin—atherosclerosis	0.000779	0.00262	CcSEcCtD
Cyclobenzaprine—Chest pain—Simvastatin—atherosclerosis	0.000778	0.00262	CcSEcCtD
Cyclobenzaprine—Myalgia—Simvastatin—atherosclerosis	0.000778	0.00262	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000775	0.00261	CcSEcCtD
Cyclobenzaprine—Anxiety—Simvastatin—atherosclerosis	0.000775	0.00261	CcSEcCtD
Cyclobenzaprine—Tremor—Pravastatin—atherosclerosis	0.000774	0.00261	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000769	0.00259	CcSEcCtD
Cyclobenzaprine—Discomfort—Simvastatin—atherosclerosis	0.000769	0.00259	CcSEcCtD
Cyclobenzaprine—Angioedema—Niacin—atherosclerosis	0.000767	0.00258	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000767	0.00258	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000766	0.00258	CcSEcCtD
Cyclobenzaprine—Anorexia—Lovastatin—atherosclerosis	0.00076	0.00256	CcSEcCtD
Cyclobenzaprine—Angioedema—Pravastatin—atherosclerosis	0.000755	0.00254	CcSEcCtD
Cyclobenzaprine—Vertigo—Niacin—atherosclerosis	0.000754	0.00254	CcSEcCtD
Cyclobenzaprine—Syncope—Niacin—atherosclerosis	0.000753	0.00254	CcSEcCtD
Cyclobenzaprine—Confusional state—Simvastatin—atherosclerosis	0.000752	0.00254	CcSEcCtD
Cyclobenzaprine—Leukopenia—Niacin—atherosclerosis	0.000751	0.00253	CcSEcCtD
Cyclobenzaprine—HTR2A—connective tissue—atherosclerosis	0.000749	0.0288	CbGeAlD
Cyclobenzaprine—Urticaria—Rosuvastatin—atherosclerosis	0.000748	0.00252	CcSEcCtD
Cyclobenzaprine—Oedema—Simvastatin—atherosclerosis	0.000746	0.00251	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000746	0.00251	CcSEcCtD
Cyclobenzaprine—Malaise—Pravastatin—atherosclerosis	0.000745	0.00251	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000744	0.00251	CcSEcCtD
Cyclobenzaprine—Vertigo—Pravastatin—atherosclerosis	0.000742	0.0025	CcSEcCtD
Cyclobenzaprine—Palpitations—Niacin—atherosclerosis	0.000742	0.0025	CcSEcCtD
Cyclobenzaprine—Leukopenia—Pravastatin—atherosclerosis	0.00074	0.00249	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Niacin—atherosclerosis	0.000738	0.00249	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00073	0.00246	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000727	0.00245	CcSEcCtD
Cyclobenzaprine—Insomnia—Lovastatin—atherosclerosis	0.000721	0.00243	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Lovastatin—atherosclerosis	0.000716	0.00241	CcSEcCtD
Cyclobenzaprine—Myalgia—Niacin—atherosclerosis	0.000714	0.00241	CcSEcCtD
Cyclobenzaprine—Hypertension—Pravastatin—atherosclerosis	0.000713	0.0024	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000713	0.0024	CcSEcCtD
Cyclobenzaprine—Anorexia—Simvastatin—atherosclerosis	0.000711	0.0024	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Lovastatin—atherosclerosis	0.000711	0.0024	CcSEcCtD
Cyclobenzaprine—Insomnia—Ezetimibe—atherosclerosis	0.000707	0.00238	CcSEcCtD
Cyclobenzaprine—Chest pain—Pravastatin—atherosclerosis	0.000703	0.00237	CcSEcCtD
Cyclobenzaprine—Myalgia—Pravastatin—atherosclerosis	0.000703	0.00237	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Ezetimibe—atherosclerosis	0.000702	0.00237	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Lovastatin—atherosclerosis	0.000702	0.00237	CcSEcCtD
Cyclobenzaprine—Anxiety—Pravastatin—atherosclerosis	0.000701	0.00236	CcSEcCtD
Cyclobenzaprine—Dry mouth—Niacin—atherosclerosis	0.000699	0.00236	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Ezetimibe—atherosclerosis	0.000697	0.00235	CcSEcCtD
Cyclobenzaprine—Discomfort—Pravastatin—atherosclerosis	0.000695	0.00234	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000693	0.00234	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Lovastatin—atherosclerosis	0.000693	0.00234	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Ezetimibe—atherosclerosis	0.000688	0.00232	CcSEcCtD
Cyclobenzaprine—Fatigue—Lovastatin—atherosclerosis	0.000687	0.00232	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Niacin—atherosclerosis	0.000685	0.00231	CcSEcCtD
Cyclobenzaprine—Oedema—Niacin—atherosclerosis	0.000685	0.00231	CcSEcCtD
Cyclobenzaprine—Constipation—Lovastatin—atherosclerosis	0.000682	0.0023	CcSEcCtD
Cyclobenzaprine—Confusional state—Pravastatin—atherosclerosis	0.00068	0.00229	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Ezetimibe—atherosclerosis	0.00068	0.00229	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00068	0.00229	CcSEcCtD
Cyclobenzaprine—Asthenia—Rosuvastatin—atherosclerosis	0.000675	0.00228	CcSEcCtD
Cyclobenzaprine—Insomnia—Simvastatin—atherosclerosis	0.000675	0.00227	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000674	0.00227	CcSEcCtD
Cyclobenzaprine—Oedema—Pravastatin—atherosclerosis	0.000674	0.00227	CcSEcCtD
Cyclobenzaprine—Fatigue—Ezetimibe—atherosclerosis	0.000674	0.00227	CcSEcCtD
Cyclobenzaprine—Shock—Niacin—atherosclerosis	0.000674	0.00227	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Simvastatin—atherosclerosis	0.00067	0.00226	CcSEcCtD
Cyclobenzaprine—Constipation—Ezetimibe—atherosclerosis	0.000669	0.00225	CcSEcCtD
Cyclobenzaprine—Tachycardia—Niacin—atherosclerosis	0.000668	0.00225	CcSEcCtD
Cyclobenzaprine—Pruritus—Rosuvastatin—atherosclerosis	0.000666	0.00224	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Simvastatin—atherosclerosis	0.000665	0.00224	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Niacin—atherosclerosis	0.000662	0.00223	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00066	0.00223	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Lovastatin—atherosclerosis	0.000657	0.00222	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Simvastatin—atherosclerosis	0.000657	0.00221	CcSEcCtD
Cyclobenzaprine—Anorexia—Niacin—atherosclerosis	0.000653	0.0022	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000652	0.0022	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000652	0.0022	CcSEcCtD
Cyclobenzaprine—HTR2A—cardiovascular system—atherosclerosis	0.000652	0.0251	CbGeAlD
Cyclobenzaprine—Decreased appetite—Simvastatin—atherosclerosis	0.000648	0.00219	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000645	0.00217	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000644	0.00217	CcSEcCtD
Cyclobenzaprine—Fatigue—Simvastatin—atherosclerosis	0.000643	0.00217	CcSEcCtD
Cyclobenzaprine—Anorexia—Pravastatin—atherosclerosis	0.000643	0.00217	CcSEcCtD
Cyclobenzaprine—Hypotension—Niacin—atherosclerosis	0.00064	0.00216	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00064	0.00216	CcSEcCtD
Cyclobenzaprine—Constipation—Simvastatin—atherosclerosis	0.000638	0.00215	CcSEcCtD
Cyclobenzaprine—Urticaria—Lovastatin—atherosclerosis	0.000633	0.00214	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Lovastatin—atherosclerosis	0.00063	0.00212	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000624	0.0021	CcSEcCtD
Cyclobenzaprine—Dizziness—Rosuvastatin—atherosclerosis	0.000622	0.0021	CcSEcCtD
Cyclobenzaprine—Urticaria—Ezetimibe—atherosclerosis	0.000621	0.00209	CcSEcCtD
Cyclobenzaprine—Insomnia—Niacin—atherosclerosis	0.000619	0.00209	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Ezetimibe—atherosclerosis	0.000618	0.00208	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Niacin—atherosclerosis	0.000615	0.00207	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Simvastatin—atherosclerosis	0.000615	0.00207	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000614	0.00207	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Niacin—atherosclerosis	0.000611	0.00206	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00061	0.00206	CcSEcCtD
Cyclobenzaprine—Insomnia—Pravastatin—atherosclerosis	0.00061	0.00206	CcSEcCtD
Cyclobenzaprine—Somnolence—Niacin—atherosclerosis	0.000609	0.00205	CcSEcCtD
Cyclobenzaprine—Cyproheptadine—HRH1—atherosclerosis	0.000606	0.0479	CrCbGaD
Cyclobenzaprine—Paraesthesia—Pravastatin—atherosclerosis	0.000606	0.00204	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Niacin—atherosclerosis	0.000603	0.00203	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Pravastatin—atherosclerosis	0.000601	0.00203	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Niacin—atherosclerosis	0.000595	0.00201	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Pravastatin—atherosclerosis	0.000594	0.002	CcSEcCtD
Cyclobenzaprine—Rash—Rosuvastatin—atherosclerosis	0.000593	0.002	CcSEcCtD
Cyclobenzaprine—Dermatitis—Rosuvastatin—atherosclerosis	0.000593	0.002	CcSEcCtD
Cyclobenzaprine—Urticaria—Simvastatin—atherosclerosis	0.000593	0.002	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Simvastatin—atherosclerosis	0.00059	0.00199	CcSEcCtD
Cyclobenzaprine—Headache—Rosuvastatin—atherosclerosis	0.000589	0.00199	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Lovastatin—atherosclerosis	0.000588	0.00198	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Pravastatin—atherosclerosis	0.000586	0.00198	CcSEcCtD
Cyclobenzaprine—Fatigue—Pravastatin—atherosclerosis	0.000581	0.00196	CcSEcCtD
Cyclobenzaprine—Constipation—Pravastatin—atherosclerosis	0.000577	0.00194	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000576	0.00194	CcSEcCtD
Cyclobenzaprine—Asthenia—Lovastatin—atherosclerosis	0.000572	0.00193	CcSEcCtD
Cyclobenzaprine—Pruritus—Lovastatin—atherosclerosis	0.000564	0.0019	CcSEcCtD
Cyclobenzaprine—Asthenia—Ezetimibe—atherosclerosis	0.000561	0.00189	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Niacin—atherosclerosis	0.00056	0.00189	CcSEcCtD
Cyclobenzaprine—Nausea—Rosuvastatin—atherosclerosis	0.000559	0.00188	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Pravastatin—atherosclerosis	0.000556	0.00187	CcSEcCtD
Cyclobenzaprine—Pruritus—Ezetimibe—atherosclerosis	0.000553	0.00187	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000551	0.00186	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Simvastatin—atherosclerosis	0.00055	0.00185	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Lovastatin—atherosclerosis	0.000546	0.00184	CcSEcCtD
Cyclobenzaprine—Urticaria—Niacin—atherosclerosis	0.000544	0.00183	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Niacin—atherosclerosis	0.000541	0.00182	CcSEcCtD
Cyclobenzaprine—Urticaria—Pravastatin—atherosclerosis	0.000536	0.00181	CcSEcCtD
Cyclobenzaprine—Asthenia—Simvastatin—atherosclerosis	0.000535	0.0018	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Ezetimibe—atherosclerosis	0.000535	0.0018	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Pravastatin—atherosclerosis	0.000533	0.0018	CcSEcCtD
Cyclobenzaprine—Pruritus—Simvastatin—atherosclerosis	0.000528	0.00178	CcSEcCtD
Cyclobenzaprine—Dizziness—Lovastatin—atherosclerosis	0.000527	0.00178	CcSEcCtD
Cyclobenzaprine—Dizziness—Ezetimibe—atherosclerosis	0.000517	0.00174	CcSEcCtD
Cyclobenzaprine—CYP1A2—liver—atherosclerosis	0.000516	0.0198	CbGeAlD
Cyclobenzaprine—Diarrhoea—Simvastatin—atherosclerosis	0.00051	0.00172	CcSEcCtD
Cyclobenzaprine—Vomiting—Lovastatin—atherosclerosis	0.000507	0.00171	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Niacin—atherosclerosis	0.000505	0.0017	CcSEcCtD
Cyclobenzaprine—Rash—Lovastatin—atherosclerosis	0.000503	0.00169	CcSEcCtD
Cyclobenzaprine—Dermatitis—Lovastatin—atherosclerosis	0.000502	0.00169	CcSEcCtD
Cyclobenzaprine—Headache—Lovastatin—atherosclerosis	0.0005	0.00168	CcSEcCtD
Cyclobenzaprine—Vomiting—Ezetimibe—atherosclerosis	0.000497	0.00168	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Pravastatin—atherosclerosis	0.000497	0.00167	CcSEcCtD
Cyclobenzaprine—Dizziness—Simvastatin—atherosclerosis	0.000493	0.00166	CcSEcCtD
Cyclobenzaprine—Rash—Ezetimibe—atherosclerosis	0.000493	0.00166	CcSEcCtD
Cyclobenzaprine—Dermatitis—Ezetimibe—atherosclerosis	0.000493	0.00166	CcSEcCtD
Cyclobenzaprine—Asthenia—Niacin—atherosclerosis	0.000491	0.00166	CcSEcCtD
Cyclobenzaprine—Headache—Ezetimibe—atherosclerosis	0.00049	0.00165	CcSEcCtD
Cyclobenzaprine—Pruritus—Niacin—atherosclerosis	0.000485	0.00163	CcSEcCtD
Cyclobenzaprine—Asthenia—Pravastatin—atherosclerosis	0.000484	0.00163	CcSEcCtD
Cyclobenzaprine—Pruritus—Pravastatin—atherosclerosis	0.000477	0.00161	CcSEcCtD
Cyclobenzaprine—Vomiting—Simvastatin—atherosclerosis	0.000474	0.0016	CcSEcCtD
Cyclobenzaprine—Nausea—Lovastatin—atherosclerosis	0.000474	0.0016	CcSEcCtD
Cyclobenzaprine—Rash—Simvastatin—atherosclerosis	0.00047	0.00159	CcSEcCtD
Cyclobenzaprine—Dermatitis—Simvastatin—atherosclerosis	0.00047	0.00158	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Niacin—atherosclerosis	0.000469	0.00158	CcSEcCtD
Cyclobenzaprine—Headache—Simvastatin—atherosclerosis	0.000467	0.00158	CcSEcCtD
Cyclobenzaprine—Nausea—Ezetimibe—atherosclerosis	0.000465	0.00157	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Pravastatin—atherosclerosis	0.000461	0.00156	CcSEcCtD
Cyclobenzaprine—Dizziness—Niacin—atherosclerosis	0.000453	0.00153	CcSEcCtD
Cyclobenzaprine—Dizziness—Pravastatin—atherosclerosis	0.000446	0.0015	CcSEcCtD
Cyclobenzaprine—Nausea—Simvastatin—atherosclerosis	0.000443	0.00149	CcSEcCtD
Cyclobenzaprine—Vomiting—Niacin—atherosclerosis	0.000435	0.00147	CcSEcCtD
Cyclobenzaprine—Rash—Niacin—atherosclerosis	0.000432	0.00146	CcSEcCtD
Cyclobenzaprine—Dermatitis—Niacin—atherosclerosis	0.000431	0.00145	CcSEcCtD
Cyclobenzaprine—Headache—Niacin—atherosclerosis	0.000429	0.00145	CcSEcCtD
Cyclobenzaprine—Vomiting—Pravastatin—atherosclerosis	0.000429	0.00145	CcSEcCtD
Cyclobenzaprine—Rash—Pravastatin—atherosclerosis	0.000425	0.00143	CcSEcCtD
Cyclobenzaprine—Dermatitis—Pravastatin—atherosclerosis	0.000425	0.00143	CcSEcCtD
Cyclobenzaprine—Headache—Pravastatin—atherosclerosis	0.000422	0.00142	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—HRH1—atherosclerosis	0.000418	0.0331	CrCbGaD
Cyclobenzaprine—Nortriptyline—HRH1—atherosclerosis	0.00041	0.0324	CrCbGaD
Cyclobenzaprine—Nausea—Niacin—atherosclerosis	0.000407	0.00137	CcSEcCtD
Cyclobenzaprine—HTR2A—liver—atherosclerosis	0.000403	0.0155	CbGeAlD
Cyclobenzaprine—Nausea—Pravastatin—atherosclerosis	0.000401	0.00135	CcSEcCtD
Cyclobenzaprine—Trimipramine—HRH1—atherosclerosis	0.000386	0.0305	CrCbGaD
Cyclobenzaprine—Diphenhydramine—HRH1—atherosclerosis	0.000379	0.03	CrCbGaD
Cyclobenzaprine—CYP3A4—liver—atherosclerosis	0.000373	0.0144	CbGeAlD
Cyclobenzaprine—Promethazine—HRH1—atherosclerosis	0.000372	0.0294	CrCbGaD
Cyclobenzaprine—Doxepin—HRH1—atherosclerosis	0.000368	0.0291	CrCbGaD
Cyclobenzaprine—CYP2D6—liver—atherosclerosis	0.000367	0.0141	CbGeAlD
Cyclobenzaprine—Orphenadrine—HRH1—atherosclerosis	0.000359	0.0284	CrCbGaD
Cyclobenzaprine—Promazine—HRH1—atherosclerosis	0.000327	0.0259	CrCbGaD
Cyclobenzaprine—Tamoxifen—ESR2—atherosclerosis	0.000311	0.0246	CrCbGaD
Cyclobenzaprine—Imipramine—HRH1—atherosclerosis	0.000287	0.0227	CrCbGaD
Cyclobenzaprine—Amitriptyline—HRH1—atherosclerosis	0.000285	0.0225	CrCbGaD
Cyclobenzaprine—Tamoxifen—ESR1—atherosclerosis	0.000192	0.0151	CrCbGaD
Cyclobenzaprine—Nortriptyline—ALB—atherosclerosis	9.47e-05	0.00749	CrCbGaD
Cyclobenzaprine—Amitriptyline—ALB—atherosclerosis	6.57e-05	0.0052	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GHRL—atherosclerosis	3.68e-05	0.000951	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.64e-05	0.00094	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	3.6e-05	0.000929	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOA4—atherosclerosis	3.56e-05	0.00092	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	3.55e-05	0.000917	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.51e-05	0.000908	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LTA4H—atherosclerosis	3.46e-05	0.000894	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCG8—atherosclerosis	3.46e-05	0.000894	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCR2—atherosclerosis	3.43e-05	0.000886	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EDNRA—atherosclerosis	3.43e-05	0.000886	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	3.42e-05	0.000883	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLTP—atherosclerosis	3.38e-05	0.000873	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL6—atherosclerosis	3.35e-05	0.000866	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GHRL—atherosclerosis	3.34e-05	0.000864	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CCL2—atherosclerosis	3.29e-05	0.000851	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL4—atherosclerosis	3.28e-05	0.000847	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—KNG1—atherosclerosis	3.23e-05	0.000835	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AGTR1—atherosclerosis	3.21e-05	0.00083	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.13e-05	0.000809	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.11e-05	0.000804	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.09e-05	0.000799	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOA2—atherosclerosis	3.06e-05	0.000792	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.02e-05	0.000781	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—KNG1—atherosclerosis	2.93e-05	0.000758	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCG8—atherosclerosis	2.93e-05	0.000757	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LTA4H—atherosclerosis	2.93e-05	0.000757	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—UTS2—atherosclerosis	2.92e-05	0.000755	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AGTR1—atherosclerosis	2.92e-05	0.000753	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.89e-05	0.000748	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CX3CR1—atherosclerosis	2.8e-05	0.000724	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASR—atherosclerosis	2.8e-05	0.000724	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.78e-05	0.000717	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CX3CL1—atherosclerosis	2.75e-05	0.00071	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.74e-05	0.000707	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.73e-05	0.000706	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—EDN1—atherosclerosis	2.72e-05	0.000703	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CCL5—atherosclerosis	2.7e-05	0.000698	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.61e-05	0.000674	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CNR2—atherosclerosis	2.61e-05	0.000673	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CXCL8—atherosclerosis	2.6e-05	0.000673	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MMP3—atherosclerosis	2.6e-05	0.000672	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	2.59e-05	0.00067	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LCAT—atherosclerosis	2.57e-05	0.000664	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—FABP4—atherosclerosis	2.57e-05	0.000664	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PRKCG—atherosclerosis	2.57e-05	0.000664	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOA4—atherosclerosis	2.52e-05	0.000652	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.48e-05	0.000641	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EDN1—atherosclerosis	2.47e-05	0.000639	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCL5—atherosclerosis	2.45e-05	0.000634	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.44e-05	0.000629	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PRKCG—atherosclerosis	2.33e-05	0.000603	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VWF—atherosclerosis	2.32e-05	0.0006	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCG1—atherosclerosis	2.32e-05	0.000599	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOC3—atherosclerosis	2.31e-05	0.000596	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LDLR—atherosclerosis	2.29e-05	0.000593	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.29e-05	0.000592	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.26e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.26e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AGT—atherosclerosis	2.26e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL3—atherosclerosis	2.24e-05	0.000579	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LCAT—atherosclerosis	2.18e-05	0.000563	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—FABP4—atherosclerosis	2.18e-05	0.000563	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOA2—atherosclerosis	2.17e-05	0.000561	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.17e-05	0.000561	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.17e-05	0.000561	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.17e-05	0.000561	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.15e-05	0.000554	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NCF1—atherosclerosis	2.15e-05	0.000554	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOA4—atherosclerosis	2.14e-05	0.000552	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	2.1e-05	0.000543	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—F2—atherosclerosis	2.09e-05	0.00054	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LPA—atherosclerosis	2.07e-05	0.000535	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AGT—atherosclerosis	2.05e-05	0.00053	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDNRA—atherosclerosis	2.03e-05	0.000523	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCR2—atherosclerosis	2.03e-05	0.000523	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CYBA—atherosclerosis	2.02e-05	0.000521	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—BGN—atherosclerosis	2.01e-05	0.000519	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2e-05	0.000517	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CG—atherosclerosis	2e-05	0.000516	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.99e-05	0.000513	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PARP1—atherosclerosis	1.98e-05	0.00051	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GHRL—atherosclerosis	1.98e-05	0.00051	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PLAT—atherosclerosis	1.98e-05	0.00051	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.94e-05	0.000502	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.91e-05	0.000494	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.91e-05	0.000494	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—F2—atherosclerosis	1.9e-05	0.00049	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.87e-05	0.000482	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.85e-05	0.000477	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.84e-05	0.000475	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.84e-05	0.000475	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOA2—atherosclerosis	1.84e-05	0.000475	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.84e-05	0.000475	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.82e-05	0.00047	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.82e-05	0.000469	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CG—atherosclerosis	1.82e-05	0.000469	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.79e-05	0.000462	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LPA—atherosclerosis	1.76e-05	0.000454	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KNG1—atherosclerosis	1.73e-05	0.000448	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AGTR1—atherosclerosis	1.72e-05	0.000445	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—BGN—atherosclerosis	1.7e-05	0.000439	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCL2—atherosclerosis	1.69e-05	0.000437	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.69e-05	0.000436	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOA5—atherosclerosis	1.68e-05	0.000435	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.68e-05	0.000434	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.68e-05	0.000434	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PLG—atherosclerosis	1.68e-05	0.000434	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.66e-05	0.000428	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.65e-05	0.000426	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.65e-05	0.000425	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.64e-05	0.000423	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.64e-05	0.000422	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.63e-05	0.00042	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.62e-05	0.000419	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.62e-05	0.000419	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.6e-05	0.000414	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SOCS3—atherosclerosis	1.59e-05	0.000411	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CETP—atherosclerosis	1.59e-05	0.00041	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.59e-05	0.00041	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.58e-05	0.000409	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.57e-05	0.000404	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP3—atherosclerosis	1.54e-05	0.000397	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF2—atherosclerosis	1.53e-05	0.000395	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.52e-05	0.000393	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.5e-05	0.000387	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOB—atherosclerosis	1.48e-05	0.000383	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCL8—atherosclerosis	1.47e-05	0.00038	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDN1—atherosclerosis	1.46e-05	0.000377	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL5—atherosclerosis	1.45e-05	0.000374	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.45e-05	0.000374	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.44e-05	0.000371	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.42e-05	0.000367	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.42e-05	0.000367	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.42e-05	0.000367	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.42e-05	0.000367	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LPL—atherosclerosis	1.42e-05	0.000366	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.4e-05	0.000363	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.4e-05	0.000362	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.4e-05	0.000361	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LIPC—atherosclerosis	1.4e-05	0.00036	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOC3—atherosclerosis	1.39e-05	0.000358	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	1.38e-05	0.000356	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LDLR—atherosclerosis	1.38e-05	0.000356	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LPA—atherosclerosis	1.36e-05	0.00035	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CETP—atherosclerosis	1.35e-05	0.000348	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SPP1—atherosclerosis	1.34e-05	0.000347	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	1.34e-05	0.000345	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—BGN—atherosclerosis	1.31e-05	0.000339	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.3e-05	0.000336	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.29e-05	0.000333	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.28e-05	0.000331	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.25e-05	0.000324	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.25e-05	0.000323	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	1.24e-05	0.000321	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.22e-05	0.000314	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AGT—atherosclerosis	1.21e-05	0.000313	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.21e-05	0.000312	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LEP—atherosclerosis	1.19e-05	0.000307	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOE—atherosclerosis	1.19e-05	0.000307	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CAV1—atherosclerosis	1.18e-05	0.000304	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOA1—atherosclerosis	1.17e-05	0.000303	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ESR1—atherosclerosis	1.13e-05	0.000293	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—F2—atherosclerosis	1.12e-05	0.000289	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.1e-05	0.000284	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.1e-05	0.000284	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.08e-05	0.00028	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.08e-05	0.00028	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.08e-05	0.000278	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	1.07e-05	0.000277	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.07e-05	0.000276	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LDLR—atherosclerosis	1.06e-05	0.000275	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOB—atherosclerosis	1.05e-05	0.000272	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CETP—atherosclerosis	1.04e-05	0.000268	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	1.03e-05	0.000265	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.02e-05	0.000264	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INS—atherosclerosis	1.02e-05	0.000262	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LPL—atherosclerosis	1e-05	0.00026	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL2—atherosclerosis	9.99e-06	0.000258	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.95e-06	0.000257	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1—atherosclerosis	9.82e-06	0.000254	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GPX1—atherosclerosis	9.8e-06	0.000253	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CD36—atherosclerosis	9.55e-06	0.000247	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.39e-06	0.000243	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	9.32e-06	0.000241	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMOX1—atherosclerosis	9.31e-06	0.00024	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.05e-06	0.000234	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOB—atherosclerosis	8.92e-06	0.00023	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	8.9e-06	0.00023	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARA—atherosclerosis	8.88e-06	0.000229	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTM1—atherosclerosis	8.67e-06	0.000224	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AGT—atherosclerosis	8.6e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LPL—atherosclerosis	8.51e-06	0.00022	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOE—atherosclerosis	8.42e-06	0.000218	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.37e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CAV1—atherosclerosis	8.35e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOA1—atherosclerosis	8.33e-06	0.000215	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GPX1—atherosclerosis	8.31e-06	0.000215	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CD36—atherosclerosis	8.09e-06	0.000209	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	7.9e-06	0.000204	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTHFR—atherosclerosis	7.67e-06	0.000198	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	7.63e-06	0.000197	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.6e-06	0.000196	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARA—atherosclerosis	7.52e-06	0.000194	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	7.51e-06	0.000194	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARG—atherosclerosis	7.34e-06	0.00019	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AGT—atherosclerosis	7.28e-06	0.000188	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—INS—atherosclerosis	7.2e-06	0.000186	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.18e-06	0.000186	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	7.14e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOE—atherosclerosis	7.14e-06	0.000184	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CAV1—atherosclerosis	7.07e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	7.07e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOA1—atherosclerosis	7.05e-06	0.000182	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	6.95e-06	0.000179	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	6.93e-06	0.000179	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOB—atherosclerosis	6.88e-06	0.000178	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.69e-06	0.000173	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALB—atherosclerosis	6.6e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LPL—atherosclerosis	6.57e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	6.44e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	6.41e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GPX1—atherosclerosis	6.41e-06	0.000166	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	6.35e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NOS3—atherosclerosis	6.31e-06	0.000163	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CD36—atherosclerosis	6.24e-06	0.000161	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARG—atherosclerosis	6.22e-06	0.000161	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—INS—atherosclerosis	6.1e-06	0.000157	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	6.07e-06	0.000157	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.92e-06	0.000153	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	5.89e-06	0.000152	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARA—atherosclerosis	5.8e-06	0.00015	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.77e-06	0.000149	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AGT—atherosclerosis	5.62e-06	0.000145	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALB—atherosclerosis	5.59e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOE—atherosclerosis	5.51e-06	0.000142	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CAV1—atherosclerosis	5.46e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOA1—atherosclerosis	5.44e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NOS3—atherosclerosis	5.35e-06	0.000138	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.97e-06	0.000128	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.89e-06	0.000126	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARG—atherosclerosis	4.8e-06	0.000124	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—INS—atherosclerosis	4.7e-06	0.000122	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—atherosclerosis	4.44e-06	0.000115	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALB—atherosclerosis	4.31e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NOS3—atherosclerosis	4.13e-06	0.000107	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	4.09e-06	0.000106	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.77e-06	9.75e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKT1—atherosclerosis	2.9e-06	7.49e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKT1—atherosclerosis	2.46e-06	6.35e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.9e-06	4.9e-05	CbGpPWpGaD
